Through a wide range of skills, experience and collaborations, Dr Lim has made substantial advances into Alzheimer’s disease, particularly in uncovering biological processes that underpin cognitive decline in the earliest disease stages. This now underpins the design of multiple clinical trials. She has demonstrated a sustained upward trajectory in her career, with 54 research papers (28 first, 26 corresponding; cited >1400 times), and ~$2M of CIA funding from NHMRC, international and industry. She has also had 14 invitations to speak at conferences and won 12 prestigious research awards.